TrialBreast cancer research and treatment2016

Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance.

Kenichi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.